Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2022
Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantationSarah B Doernberg, American Journal of Infection Control|July 22, 2011
Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli in an urban county hospitalSarah B Doernberg, Lisa G WinstonInfectious Disease Clinics of North America|July 9, 2017
Antimicrobial Stewardship Approaches in the Intensive Care UnitSarah B Doernberg, Henry F ChambersAntimicrobial Resistance and Infection Control|December 4, 2015
Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysisSarah B Doernberg, Victoria Dudas, Kavita K TrivediClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2025
A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure InfectionFelicia Ruffin, Katherine N Sutton, Julie Miller, et al.Antimicrobial Agents and Chemotherapy|May 13, 2020
Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are ChosenThomas L HollandClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2023
Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical PracticeDaniel J Minter, Ayesha Appa, Henry F Chambers, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2012
Does doxycycline protect against development of Clostridium difficile infection?Sarah B Doernberg, Lisa G Winston, Daniel H Deck, et al.Trials|May 16, 2022
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trialNicholas A Turner, Smitha Zaharoff, Heather King, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2022
Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases DiagnosticsRobin Patel, Ephraim L Tsalik, Scott Evans, et al.Pageof 13